Hyperinsulinaemia in cancer

Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity

Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860

Role of Insulin Resistance in Human Disease

Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154

Use and Abuse of HOMA Modeling

Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114

Body Fatness and Cancer — Viewpoint of the IARC Working Group

Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596

The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice

Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058

Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer

André, F., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H. S., Iwata, H., Conte, P., Mayer, I. A., Kaufman, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813904 · Cited by 2,622

Pathophysiology of human visceral obesity: an update

Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583

Metformin and reduced risk of cancer in diabetic patients

Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388

Insulin and insulin-like growth factor signalling in neoplasia

Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059

Insulin Receptor Signaling in Normal and Insulin-Resistant StatesPreprint

Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,550

PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting

Thorpe, L. M., Yuzugullu, H., & Zhao, J. J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3860 · Cited by 1,405

Adipogenesis and metabolic health

Ghaben, A. L., & Scherer, P. E. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0093-z · Cited by 1,395

Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease

Shulman, G. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1011035 · Cited by 1,126

Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk

Stern, J. H., Rutkowski, J. M., & Scherer, P. E. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.011 · Cited by 1,031

Ras in Cancer and Developmental Diseases

Fernández‐Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 1,001

Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study

Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 978

Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies

Tsilidis, K. K., Kasimis, J. C., López, D. S., Ntzani, E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 885

Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets

Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885

Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity

Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 852

Insulin Resistance and Hyperinsulinemia

Shanik, M. H., Xu, Y., Škrha, J., Dankner, R., Zick, Y., & Roth, J. (2008) · Diabetes Care · doi:10.2337/dc08-s264 · Cited by 791

Life without white fat: a transgenic mousePreprint

Moitra, J., Mason, M. M., Olive, M., Krylov, D. Y., Gavrilova, O., Marcus‐Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., et al. (1998) · Genes & Development · doi:10.1101/gad.12.20.3168 · Cited by 776

Biochemical and cellular properties of insulin receptor signalling

Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739

Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

Hopkins, B. D., Pauli, C., Du, X., Wang, D. G., Li, X., Wu, D., Amadiume, S. C., Goncalves, M. D., Hodakoski, C., Lundquist, M. R., et al. (2018) · Nature · doi:10.1038/s41586-018-0343-4 · Cited by 706

Meta‐analysis: effect of hormone‐replacement therapy on components of the metabolic syndrome in postmenopausal women

Salpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., & Salpeter, E. E. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00545.x · Cited by 640

Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy.

Raffaghello, L., Lee, C., Safdie, F. M., Wei, M., Madia, F., Bianchi, G., & Longo, V. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708100105 · Cited by 587

A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer

Tsuchida, T., Lee, Y. A., Fujiwara, N., Ybanez, M., Allen, B., Martins, S., Fiel, M. I., Goossens, N., Chou, H.-I., Hoshida, Y., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.011 · Cited by 583

Sp1 and the ‘hallmarks of cancer’

Beishline, K., & Azizkhan‐Clifford, J. (2014) · FEBS Journal · doi:10.1111/febs.13148 · Cited by 541

Diabetes, pancreatogenic diabetes, and pancreatic cancer

Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L. (2017) · Diabetes · doi:10.2337/db16-1477 · Cited by 516

40 YEARS OF IGF1: IGF1 receptor signaling pathways

Hakuno, F., & Takahashi, S. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0311 · Cited by 462

Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes

Abdul‐Ghani, M. A., Norton, L., & DeFronzo, R. A. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0029 · Cited by 454

The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women

Harvie, M., Wright, C., Pegington, M., McMullan, D., Mitchell, E., Martin, B., Cutler, R. G., Evans, G., Whiteside, S., Maudsley, S., et al. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000792 · Cited by 431

Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

Law, J. H., Habibi, G., Hu, K., Masoudi, H., Wang, M. Y. C., Stratford, A. L., Park, E., Gee, J. M. W., Finlay, P., Jones, H. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2755 · Cited by 404

Insulin Receptor Isoforms in Physiology and Disease: An Updated View

Belfiore, A., Malaguarnera, R., Vella, V., Lawrence, M. C., Sciacca, L., Frasca, F., Morrione, A., & Vigneri, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00073 · Cited by 390

Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes

Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369

Functionally distinct insulin receptors generated by tissue‐specific alternative splicing.

Mosthaf, L., Grako, K. A., Dull, T. J., Coussens, L. M., Ullrich, A., & McClain, D. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07416.x · Cited by 366

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

Kordes, S., Pollak, M. N., Zwinderman, A. H., Mathôt, R. A., Weterman, M. J., Beeker, A., Punt, C. J., Richel, D. J., & Wilmink, J. W. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00027-3 · Cited by 361

Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication

Funcke, J., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 357

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

Burtrum, D. B., Zhu, Z., Lu, D., Anderson, D. M., Prewett, M. C., PEREIRA, D. S., Bassi, R., Abdullah, R., Hooper, A. T., Koo, H., et al. (2003) · PubMed · Cited by 352

Functional expression of sodium-glucose transporters in cancer

Scafoglio, C., Hirayama, B. A., Kepe, V., Liu, J., Ghezzi, C., Satyamurthy, N., Moatamed, N. A., Huang, J., Koepsell, H., Barrio, J. R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511698112 · Cited by 343

Disrupting insulin-like growth factor signaling as a potential cancer therapy

Sachdev, D., & Yee, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0080 · Cited by 341

A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men

Ma, J., Giovannucci, E. L., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J. M., & Stampfer, M. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh082 · Cited by 331

Repurposing metformin for cancer treatment: current clinical studies

Chae, Y. K., Arya, A., Malecek, M., Shin, D. S., Carneiro, B. A., Chandra, S., Kaplan, J. B., Kalyan, A., Altman, J. K., Platanias, L. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8194 · Cited by 328

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

Arteaga, C. L., Kitten, L. J., Coronado, E. B., Jacobs, S., Kull, F. C., Allred, D. C., & Osborne, C. K. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114315 · Cited by 328

Tissue-Specific Expression of Two Alternatively Spliced Insulin Receptor mRNAs in Man

Moller, D. E., Yokota, A., Caro, J. F., & Flier, J. S. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-8-1263 · Cited by 326

Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index

Lee, C. D., Safdie, F. M., Raffaghello, L., Wei, M., Madia, F., Parrella, E., Hwang, D., Cohen, P., Bianchi, G., & Longo, V. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3228 · Cited by 326

Disrupting Insulin-Like Growth Factor Signaling as a Potential Cancer Therapy

Sachdev, D., & Yee, D. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-06-0080 · Cited by 315

Ethnic-Specific Criteria for Classification of Body Mass Index: A Perspective for Asian Indians and American Diabetes Association Position Statement

Misra, A. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0007 · Cited by 292

Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes

Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A. M., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 283

Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting

BAILYES, E. M., NAVÉ, B. T., Soos, M. A., ORR, S. R., Hayward, A. C., & Siddle, K. (1997) · Biochemical Journal · doi:10.1042/bj3270209 · Cited by 278

Cancer-Associated PIK3CA Mutations in Overgrowth Disorders

Madsen, R. R., Vanhaesebroeck, B., & Semple, R. K. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.08.003 · Cited by 276

The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

de Groot, S., Vreeswijk, M. P. G., Welters, M. J. P., Gravesteijn, G., Boei, J. J. W. A., Jochems, A., Houtsma, D., Putter, H., van der Hoeven, J. J. M., Nortier, J. W. R., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1663-5 · Cited by 265

The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study

Bauersfeld, S. P., Keßler, C. S., Wischnewsky, M. B., Jaensch, A., Steckhan, N., Stange, R., Kunz, B., Brückner, B., Sehouli, J., & Michalsen, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4353-2 · Cited by 260

Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 Adipocytes

Ugi, S., Imamura, T., Maegawa, H., Egawa, K., Yoshizaki, T., Shi, K., Obata, T., Ebina, Y., Kashiwagi, A., & Olefsky, J. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8778-8789.2004 · Cited by 252

The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration

Villani, L. A., Smith, B. K., Marcinko, K., Ford, R. J., Broadfield, L. A., Green, A. E., Houde, V. P., Muti, P. C., Tsakiridis, T. K., & Steinberg, G. R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.08.014 · Cited by 247

Pancreatic β Cell Regeneration as a Possible Therapy for Diabetes

Aguayo‐Mazzucato, C., & Bonner‐Weir, S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.007 · Cited by 247

Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

Ulanet, D. B., Ludwig, D. L., Kahn, C. R., & Hanahan, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914076107 · Cited by 235

The Splicing Factor RBM4 Controls Apoptosis, Proliferation, and Migration to Suppress Tumor Progression

Wang, Y., Chen, D., Qian, H., Tsai, Y., Shao, S., Liu, Q., Dominguez, D., & Wang, Z. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.010 · Cited by 224

Insulin receptor expression by human prostate cancers

Cox, M., Gleave, M. E., Zakikhani, M., Bell, R. H., Piura, E., Vickers, E., Cunningham, M., Larsson, O. S., Fazli, L., & Pollak, M. (2008) · The Prostate · doi:10.1002/pros.20852 · Cited by 224

Safety and feasibility of fasting in combination with platinum-based chemotherapy

Dorff, T. B., Groshen, S. G., García, A. A., Shah, M., Tsao-Wei, D. D., Pham, H. Q., Cheng, C., Brandhorst, S., Cohen, P., Wei, M., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2370-6 · Cited by 219

Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy

Safdie, F. M., Brandhorst, S., Wei, M., Wang, W., Lee, C. D., Hwang, S., Conti, P. S., Chen, T. C., & Longo, V. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044603 · Cited by 201

Cellular Mechanism by Which Estradiol Protects Female Ovariectomized Mice From High-Fat Diet-Induced Hepatic and Muscle Insulin Resistance

Camporez, J. P., Jornayvaz, F. R., Lee, H., Kanda, S., Guigni, B. A., Kahn, M., Samuel, V. T., Carvalho, C. R. D. O., Petersen, K. F., Jurczak, M. J., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1989 · Cited by 197

Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation

Farabaugh, S. M., Boone, D. N., & Lee, A. V. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00059 · Cited by 190

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

Sachdev, D., Li, S. L., Hartell, J. S., Fujita‐Yamaguchi, Y., Miller, J. S., & Yee, D. (2003) · PubMed · Cited by 190

Serum C‐peptide, IGFBP‐1 and IGFBP‐2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition

Jenab, M., Ríboli, E., Cleveland, R. J., Norat, T., Rinaldi, S., Nieters, A., Biessy, C., Tjønneland, A. M., Olsen, A., Overvad, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22697 · Cited by 187

Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?

Yee, D. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs258 · Cited by 177

Insulin resistance and body composition in cancer patients

Dev, R., Bruera, E. D., & Dalal, S. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx815 · Cited by 177

Are Metformin Doses Used in Murine Cancer Models Clinically Relevant

Chandel, N. S., Avizonis, D., Reczek, C. R., Weinberg, S. E., Menz, S., Neuhaus, R., Christian, S., Haegebarth, A., Algire, C., & Pollak, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.010 · Cited by 176

Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer

Okumura, S., Kaido, T., Hamaguchi, Y., Kobayashi, A., Shirai, H., Yao, S., Yagi, S., Kamo, N., Hatano, E., Okajima, H., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6077-y · Cited by 171

Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth

Xia, S., Lin, R., Jin, L., Zhao, L., Kang, H., Pan, Y., Liu, S., Qian, G., Qian, Z., Konstantakou, E., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.010 · Cited by 171

The insulin receptor: a prototype for dimeric, allosteric membrane receptors?

MEYTS, P. D. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.06.003 · Cited by 165

Preventable Cancer Burden Associated With Poor Diet in the United States

Zhang, F. F., Cudhea, F., Shan, Z., Michaud, D. S., Imamura, F., Eom, H., Ruan, M., Rehm, C. D., Liu, J., Du, M., et al. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz034 · Cited by 165

Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression

Hancock, M., Meyer, R. C., Mistry, M., Khetani, R. S., Wagschal, A., Shin, T., Sui, S. J. H., Näär, A. M., & Flanagan, J. G. (2019) · Cell · doi:10.1016/j.cell.2019.02.030 · Cited by 160

β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity

Mezza, T., Cinti, F., CEFALO, C. M. A., Pontecorvi, A., Kulkarni, R., & Giaccari, A. (2019) · Diabetes · doi:10.2337/db18-0856 · Cited by 160

Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study

Yuan, S., Kar, S., Carter, P., Vithayathil, M. K., Mason, A. M., Burgess, S., & Larsson, S. C. (2020) · Diabetes · doi:10.2337/db20-0084 · Cited by 154

Hormonal, Metabolic, and Inflammatory Profiles and Endometrial Cancer Risk Within the EPIC Cohort—A Factor Analysis

Dossus, L., Lukanova, A., Rinaldi, S., Allen, N. E., Cust, A. E., Becker, S., Tjønneland, A. M., Hansen, L., Overvad, K., Chabbert‐Buffet, N., et al. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws309 · Cited by 154

Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones

Yakar, S., Núñez, N. P., Pennisi, P. A., Brodt, P., Sun, H., Fallavollita, L., Zhao, H., Scavo, L. M., Novosyadlyy, R., Kurshan, N., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0311 · Cited by 154

Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.

Webster, N. J. G., Resnik, J. L., Reichart, D. B., Strauss, B. E., Haas, M., & Seely, B. L. (1996) · PubMed · Cited by 149

Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice

Chang, H.-H., Moro, A., Takakura, K., Su, H., Mo, A., Nakanishi, M., Waldron, R. T., French, S. W., Dawson, D. W., Hines, O. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184455 · Cited by 145

Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation

Klement, R. J. (2017) · Medical Oncology · doi:10.1007/s12032-017-0991-5 · Cited by 144

Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population‐based observational study

Tsujimoto, T., Kajio, H., & Sugiyama, T. (2017) · International Journal of Cancer · doi:10.1002/ijc.30729 · Cited by 143

The broken “Off” switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance

Ruvolo, P. P. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.08.002 · Cited by 143

Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle Study

Irwin, M. L., Duggan, C. R., Wang, C., Smith, A. W., McTiernan, A., Baumgartner, R., Baumgartner, K. B., Bernstein, L., & Ballard-Barbash, R. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4752 · Cited by 142

Proinsulin and C-peptide: A review

Kitabchi, A. E. (1977) · Metabolism · doi:10.1016/0026-0495(77)90099-3 · Cited by 140

Effects of short-term fasting on cancer treatment

de Groot, S., Pijl, H., van der Hoeven, J. J. M., & Kroep, J. R. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1189-9 · Cited by 134

Chronic Hyperglycemia Predisposes to Exaggerated Inflammatory Response and Leukocyte Dysfunction in Akita Mice

Gyurko, R., Siqueira, C. C., Caldon, N., Gao, L., Kantarcı, A., & Dyke, T. E. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7250 · Cited by 133

Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing Factors

Chettouh, H., Fartoux, L., Aoudjehane, L., Wendum, D., Clapéron, A., Chrétien, Y., Rey, C., Scatton, O., Soubrane, O., Conti, F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3824 · Cited by 131

Breast Cancer Risk in Metabolically Healthy but Overweight Postmenopausal Women

Gunter, M. J., Xie, X., Xue, X., Kabat, G. C., Rohan, T. E., Wassertheil-Smoller, S. W., Ho, G., Wylie‐Rosett, J., Greco, T., Yu, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2317 · Cited by 131

Deletion of serine/arginine‐rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice

Sen, S., Langiewicz, M., Jumaa, H., & Webster, N. J. G. (2014) · Hepatology · doi:10.1002/hep.27380 · Cited by 130

Regulation of IGF -1 signaling by microRNAs

Jung, H. J., & Suh, Y. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2014.00472 · Cited by 124

Standardization of Negative Controls in Diagnostic Immunohistochemistry

Torlakovic, E., Francis, G. D., Garratt, J., Gilks, C. B., Hyjek, E. M., Ibrahim, M., Miller, R. T., Nielsen, S. M., Petcu, E. B., Swanson, P. E., et al. (2014) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000069 · Cited by 124

Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival

Zheng, Q., Dunlap, S. M., Zhu, J., Downs-Kelly, E. P., Rich, J. N., Hursting, S. D., Berger, N. A., & Reizes, O. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0102 · Cited by 124

A Western-Type Diet Accelerates Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer

Llaverı́as, G., Danilo, C., Wang, Y., Witkiewicz, A. K., Daumer, K. M., Lisanti, M. P., & Frank, P. G. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100568 · Cited by 124

Modeling the Western Diet for Preclinical Investigations

Hintze, K. J., Benninghoff, A. D., Cho, C. E., & Ward, R. E. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy002 · Cited by 123

A brief perspective on insulin production

Steiner, D. F., Park, S., Støy, J., Philipson, L. H., & Bell, G. I. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01106.x · Cited by 122

Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents

Tricò, D., Natali, A., Arslanian, S. A., Mari, A., & Ferrannini, E. (2018) · JCI Insight · doi:10.1172/jci.insight.124912 · Cited by 121

Childhood obesity: Aetiology, comorbidities, and treatment

Camacho, W. J. M., Díaz, J. M. M., Ortiz, S. P., Ortiz, J. E. P., Camacho, M. A. M., & Calderón, B. P. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3203 · Cited by 119

Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation

Zhang, H., Fagan, D. H., Zeng, X., Freeman, K. T., Sachdev, D., & Yee, D. (2010) · Oncogene · doi:10.1038/onc.2010.17 · Cited by 119

HMGA1 in cancer: Cancer classification by location

Wang, Y., Hu, L. T., Zheng, Y., & Guo, L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14082 · Cited by 118

SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia

Nasiri, A. R., Rodrigues, M. R. D. S., Li, Z., Leitner, B. P., & Perry, R. J. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0203-1 · Cited by 116

SRp20 and CUG-BP1 Modulate Insulin Receptor Exon 11 Alternative Splicing

Sen, S., Talukdar, I., & Webster, N. J. G. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01709-08 · Cited by 114

The Obesity-Cancer Link: Lessons Learned from a Fatless Mouse

Hursting, S. D., Nunez, N. P., Varticovski, L., & Vinson, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4237 · Cited by 110

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

MYME investigators, Nanni, O., Amadori, D., DeCensi, A., Rocca, A., Freschi, A., Bologna, A., Gianni, L., Rosetti, F., Amaducci, L., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-05070-2 · Cited by 105

Prediagnostic Plasma C-Peptide and Pancreatic Cancer Risk in Men and Women

Michaud, D. S., Wolpin, B. M., Giovannucci, E. L., Liu, S., Cochrane, B. B., Manson, J. E., Pollak, M., Ma, J., & Fuchs, C. S. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0182 · Cited by 104

A Review on the Relationship between SGLT2 Inhibitors and Cancer

Lin, H.-W., & Tseng, C. (2014) · International Journal of Endocrinology · doi:10.1155/2014/719578 · Cited by 102

Hyperinsulinemia Predicts Fatal Liver Cancer but Is Inversely Associated With Fatal Cancer at Some Other Sites

Balkau, B., Kahn, H. S., Courbon, D., Eschwège, É., & Ducimetière, P. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.843 · Cited by 101

Proinsulin Binds with High Affinity the Insulin Receptor Isoform A and Predominantly Activates the Mitogenic Pathway

Malaguarnera, R., Sacco, A., Voci, C., Pandini, G., Vigneri, R., & Belfiore, A. (2012) · Endocrinology · doi:10.1210/en.2011-1843 · Cited by 100

Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes

Ferguson, R. D., Novosyadlyy, R., Fierz, Y., Alikhani, N., Sun, H., Yakar, S., & LeRoith, D. (2012) · Breast Cancer Research · doi:10.1186/bcr3089 · Cited by 97

Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations—Role of Carbohydrate and Energy Availability

Bojsen-Møller, K. N., Lundsgaard, A., Madsbad, S., Kiens, B., & Holst, J. J. (2018) · Diabetes · doi:10.2337/db18-0539 · Cited by 97

Obesity promotes melanoma tumor growth: Role of leptin

Brandon, E. L., Gu, J.-W., Cantwell, L. M., He, Z., Wallace, G., & Hall, J. E. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.19.9650 · Cited by 97

Endogenous Hyperinsulinemia Contributes to Pancreatic Cancer Development

Zhang, A. M. Y., Magrill, J., de Winter, T. J. J., Hu, X., Skovsø, S., Schaeffer, D. F., Kopp, J. L., & Johnson, J. D. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.003 · Cited by 97

Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer

Mulligan, A. M., O’Malley, F. P., Ennis, M., Fantus, I. G., & Goodwin, P. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9471-x · Cited by 96

A Nested Case–Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Murphy, N., Cross, A. J., Abubakar, M., Jenab, M., Aleksandrova, K., Boutron‐Ruault, M., Dossus, L., Racine, A., Kuhn, T. E., Katzke, V. A., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1001988 · Cited by 95

p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas

Hsieh, M.-H., Choe, J. H., Gadhvi, J. G., Kim, Y. J., Arguez, M. A., Palmer, M., Gerold, H., Nowak, C. M., Do, H., Mazambani, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.027 · Cited by 93

Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression

Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2009) · Diabetes · doi:10.2337/db09-1291 · Cited by 92

Minireview: Were the IGF Signaling Inhibitors All Bad?

Beckwith, H. C., & Yee, D. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1157 · Cited by 91

Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia

Gallagher, E. J., Fierz, Y., Vijayakumar, A., Haddad, N., Yakar, S., & LeRoith, D. (2011) · Oncogene · doi:10.1038/onc.2011.495 · Cited by 86

Muscleblind-like 1 (Mbnl1) Promotes Insulin Receptor Exon 11 Inclusion via Binding to a Downstream Evolutionarily Conserved Intronic Enhancer

Sen, S., Talukdar, I., Liu, Y. M., Tam, J. W. O., Reddy, S., & Webster, N. J. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095224 · Cited by 85

The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action

Werner, H., & Maor, S. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.06.007 · Cited by 83

The multifaceted effects of metformin on tumor microenvironment

Kurelac, I., Ganesh, N. U., Iorio, M. C., Porcelli, A. M., & Gasparre, G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.010 · Cited by 81

Nova1 is a master regulator of alternative splicing in pancreatic beta cells

Villate, O., Turatsinze, J., Mascali, L. G., Grieco, F. A., Nogueira, T. C., Cunha, D. A., Nardelli, T. R., Sammeth, M., Salunkhe, V. A., Esguerra, J. L. S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku861 · Cited by 80

High-fat Western diet–induced obesity contributes to increased tumor growth in mouse models of human colon cancer

O’Neill, A. M., Burrington, C. M., Gillaspie, E. A., Lynch, D. T., Horsman, M. J., & Greene, M. W. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.10.005 · Cited by 73

Highly specific role of the insulin receptor in breast cancer progression

Rostoker, R., Abelson, S., Bitton-Worms, K., Genkin, I., Ben-Shmuel, S., Dakwar, M., Orr, Z. S., Caspi, A., Tzukerman, M., & LeRoith, D. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0490 · Cited by 72

hnRNP A1 and hnRNP F Modulate the Alternative Splicing of Exon 11 of the Insulin Receptor Gene

Talukdar, I., Sen, S., Urbano, R., Thompson, J. X., Yates, J. R., & Webster, N. J. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027869 · Cited by 71

The insulin receptor translocates to the nucleus to regulate cell proliferation in liver

Amaya, M. J., de Oliveira, A. G., Guimarães, E. S., Casteluber, M. C. D. F., Carvalho, S. M., de Andrade, L. M., Pinto, M. C. X., Mennone, A., Oliveira, C. A., Resende, R. R., et al. (2013) · Hepatology · doi:10.1002/hep.26609 · Cited by 71

Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes

Wu, A., Chen, J., & Baserga, R. (2007) · Oncogene · doi:10.1038/sj.onc.1210636 · Cited by 70

Role of Insulin Receptor in the Regulation of Glucose Uptake in Neonatal Hepatocytes

Nevado, C., Valverde, Á. M., & Benito, M. (2006) · Endocrinology · doi:10.1210/en.2005-1663 · Cited by 67

Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage

Aleksic, T., Gray, N., Wu, X., Rieunier, G., Osher, E. L., Mills, J. V., Verrill, C. L., Bryant, R. J., Han, C., Hutchinson, K., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3498 · Cited by 67

Characterization of IRA/IRB hybrid insulin receptors using bioluminescence resonance energy transfer

Blanquart, C., Achi, J., & Issad, T. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.027 · Cited by 64

Structural Dynamics of Insulin Receptor and Transmembrane Signaling

Tatulian, S. A. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00805 · Cited by 64

Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin

Slaaby, R. (2015) · Scientific Reports · doi:10.1038/srep07911 · Cited by 63

Quantifying Mediating Effects of Endogenous Estrogen and Insulin in the Relation between Obesity, Alcohol Consumption, and Breast Cancer

Hvidtfeldt, U. A., Gunter, M. J., Lange, T., Chlebowski, R. T., Lane, D. S., Farhat, G. N., Freiberg, M. S., Keiding, N., Lee, J. S., Prentice, R. L., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0310 · Cited by 63

Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus

Reilly, T. P., Graziano, M. J., Janovitz, E. B., Dorr, T. E., Fairchild, C. R., Lee, F. Y., Chen, J., Wong, T., Whaley, J. M., & Tirmenstein, M. A. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0053-3 · Cited by 63

Expression and function of the insulin‐like growth factor I system in human non‐small‐cell lung cancer and normal lung cell lines

Favoni, R. E., de Cupis, A., Ravera, F., Cantoni, C., Pirani, P., Ardizzoni, A., Noonan, D. M., & Biassoni, R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560618 · Cited by 63

Hepatocellular Neoplasms Induced by Low-Number Pancreatic Islet Transplants in Autoimmune Diabetic BB/Pfd Rats

Dombrowski, F., Mathieu, C., & Evert, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2787 · Cited by 61

Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer

Kim, J., Kim, E. S., Liu, D., Lee, J. J., Solis, L. M., Behrens, C., Lippman, S. M., Hong, W. K., Wistuba, I. I., & Lee, H. (2011) · Cancer · doi:10.1002/cncr.26492 · Cited by 61

Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence

Harvie, M., & Howell, A. (2016) · Advances in Nutrition · doi:10.3945/an.115.011767 · Cited by 60

Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease

Ahearn, T. U., Peisch, S. F., Pettersson, A., Ebot, E. M., Zhou, C. K., Graff, R. E., Sinnott, J. A., Fazli, L., Judson, G. L., Bismar, T. A., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy112 · Cited by 59

Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis

Liśkiewicz, A., Liśkiewicz, D., Wojakowska, A., Polański, K., Lewin‐Kowalik, J., Kotulska, K., & Jędrzejowska–Szypułka, H. (2016) · Scientific Reports · doi:10.1038/srep21807 · Cited by 58

Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer

Wang, Y., Nasiri, A. R., Damsky, W., Perry, C. J., Zhang, X., Rabin-Court, A., Pollak, M., Shulman, G. I., & Perry, R. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.008 · Cited by 57

Insulin Receptor Isoforms A and B as well as Insulin Receptor Substrates-1 and -2 Are Differentially Expressed in Prostate Cancer

Heni, M., Hennenlotter, J., Scharpf, M. O., Lutz, S. Z., Schwentner, C., Todenhöfer, T., Schilling, D., Kühs, U., Gerber, V., Machicao, F. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050953 · Cited by 57

Adipose tissue insulin resistance due to loss of PI3K p110α leads to decreased energy expenditure and obesity

Nelson, V. L., Jiang, Y., Dickman, K. G., Ballou, L. M., & Lin, R. Z. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00625.2013 · Cited by 55

The effect of dietary fat and carbohydrate on diethylstilbestrol-induced mammary cancer in rats.

Dunning, W. F., Curtis, M. R., & Maun, M. E. (1949) · PubMed · Cited by 54

Ablation of PI3K p110-α Prevents High-Fat Diet–Induced Liver Steatosis

Chattopadhyay, M., Selinger, E. S., Ballou, L. M., & Lin, R. Z. (2011) · Diabetes · doi:10.2337/db10-0869 · Cited by 53

Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin

Jonghe, S. D., Proctor, J., Vinken, P., Feyen, B., Wynant, I., Mariën, D., Geys, H., Mamidi, R. N. V. S., & Johnson, M. D. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.09.018 · Cited by 53

Stimulation of islet cell proliferation enhances pancreatic ductal carcinogenesis in the hamster model.

Pour, P. M., & Kazakoff, K. R. (1996) · PubMed · Cited by 52

Plasma insulin, C ‐peptide and blood glucose and the risk of gastric cancer: The J apan P ublic H ealth C enter‐based prospective study

Hidaka, A., Sasazuki, S., Goto, A., Sawada, N., Shimazu, T., Yamaji, T., Iwasaki, M., Inoue, M., Noda, M., Tajiri, H., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29098 · Cited by 52

High-fat Diet Enhances Mammary Tumorigenesis and Pulmonary Metastasis and Alters Inflammatory and Angiogenic Profiles in MMTV-PyMT Mice

Sundaram, S., & Yan, L. (2016) · Anticancer Research · doi:10.21873/anticanres.11223 · Cited by 52

Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer

Ferguson, R. D., Gallagher, E. J., Cohen, D., Tobin‐Hess, A., Alikhani, N., Novosyadlyy, R., Haddad, N., Yakar, S., & LeRoith, D. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0333 · Cited by 51

IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer

Aleksic, T., Verrill, C. L., Bryant, R. J., Han, C., Worrall, A. R., Brureau, L., Larré, S., Higgins, G. S., Fazal, F., Sabbagh, A. A., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.337 · Cited by 51

EDTA Improves Stability of Whole Blood C-Peptide and Insulin to Over 24 Hours at Room Temperature

McDonald, T. J., Perry, M. H., Peake, R. W. A., Pullan, N. J., O’Connor, J., Shields, B. M., Knight, B. A., & Hattersley, A. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042084 · Cited by 49

Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women’s Health Initiative

Pan, K., Nelson, R. A., Wactawski‐Wende, J., Lee, D. J., Manson, J. E., Aragaki, A. K., Mortimer, J. E., Phillips, L. S., Rohan, T. E., Ho, G. Y. F., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz069 · Cited by 49

Quantifying insulin receptor isoform expression in FFPE breast tumors

Harrington, S. C., Weroha, S. J., Reynolds, C. A., Suman, V. J., Lingle, W. L., & Haluska, P. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.04.001 · Cited by 49

Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers

Farrington, C. C., Yuan, E., Mazhar, S., Izadmehr, S., Hurst, L., Allen-Petersen, B. L., Janghorban, M., Chung, E. M., Wolczanski, G., Galsky, M. D., et al. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49933-9 · Cited by 47

Prostate cancer cell proliferation and angiogenesis in different obese mice models

Ribeiro, A. M., Andrade, S., Pinho, F., Monteiro, J. D., Costa, M. M., Lopes, C., Águas, A. P., & Monteiro, M. P. (2010) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2010.00726.x · Cited by 47

Receptor-isoform-selective insulin analogues give tissue-preferential effects

Vienberg, S. G., Bouman, S. D., Sørensen, H., Stidsen, C. E., Kjeldsen, T., Glendorf, T., Sørensen, A. R., Olsen, G. S., Andersen, B., & Nishimura, E. (2011) · Biochemical Journal · doi:10.1042/bj20110880 · Cited by 45

Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes

Loftfield, E., Freedman, N. D., Lai, G. Y., Weinstein, S. J., McGlynn, K. A., Taylor, P. R., Männistö, S., Albanes, D., & Stolzenberg‐Solomon, R. Z. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0141 · Cited by 45

RBM4 Promotes Pancreas Cell Differentiation and Insulin Expression

Lin, J.-C., Yan, Y., Hsieh, W.-K., Peng, P.-J., Su, C.-H., & Tarn, W. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01266-12 · Cited by 45

Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas

Cheson, B. D., O'Brien, S. M., Ewer, M. S., Goncalves, M. D., Farooki, A., Lenz, G., Yu, A. F., Fisher, R. I., Zinzani, P. L., & Dreyling, M. H. (2018) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2018.11.021 · Cited by 44

Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer

Senapati, P., Kato, H., Lee, M., Leung, A., Thai, C., Sanchez, A., Gallagher, E. J., LeRoith, D., Seewaldt, V. L., Ann, D. K., et al. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0290-9 · Cited by 43

SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome

Liu, B. A., Engelmann, B. W., Jablonowski, K. D., Higginbotham, K., Stergachis, A. B., & Nash, P. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-27 · Cited by 43

Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers

Farrington, C. C., Yuan, E., Mazhar, S., Izadmehr, S., Hurst, L., Allen-Petersen, B. L., Janghorban, M., Chung, E. M., Wolczanski, G., Galsky, M. D., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011443 · Cited by 42

Toward a cancer-specific diet

Bozzetti, F., & Zupec‐Kania, B. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.01.013 · Cited by 41

Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes

Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0091 · Cited by 39

Associations of Serum Isoflavone, Adiponectin and Insulin Levels with Risk for Epithelial Ovarian Cancer: Results of a Case-control Study

Otokozawa, S., Tanaka, R., Akasaka, H., Ito, E., Asakura, S., Ohnishi, H., Saito, S., Miura, T., Saito, T., & Mori, M. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.12.4987 · Cited by 39

Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.

Pfützner, A., Kann, P. H., Pfützner, A. H., Kunt, T., Larbig, M., Weber, M. M., & Forst, T. M. (2004) · PubMed · Cited by 39

Experimental Animal Models of Pancreatic Carcinogenesis for Prevention Studies and Their Relevance to Human Disease

Takahashi, M., Hori, M., Mutoh, M., Wakabayashi, K., & Nakagama, H. (2011) · Cancers · doi:10.3390/cancers3010582 · Cited by 38

Metabolic insights from extreme human insulin resistance phenotypes

Stears, A. J., O’Rahilly, S., Semple, R. K., & Savage, D. B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.09.003 · Cited by 38

HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene

Aiello, A., Pandini, G., Sarfstein, R., Werner, H., Manfioletti, G., Vigneri, R., & Belfiore, A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.050 · Cited by 37

Insulin‐independent promotion of chemically induced hepatocellular tumor development in genetically diabetic mice

Yamasaki, K., Hayashi, Y., Okamoto, S., Osanai, M., & Lee, G. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01345.x · Cited by 36

Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2

Sarkar, P. L., Lee, W., Williams, E. D., Lubik, A. A., Stylianou, N., Shokoohmand, A., Lehman, M., Hollier, B. G., Gunter, J. H., & Nelson, C. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00481 · Cited by 35

Nonclinical Safety of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin

Bogdanffy, M. S., Stachlewitz, R. F., van Tongeren, S., Knight, B., Sharp, D. E., Ku, W. W., Hart, S. E., & Blanchard, K. T. (2014) · International Journal of Toxicology · doi:10.1177/1091581814551648 · Cited by 35

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma

Jiang, L., Zhu, W., Streicher, K. L., Morehouse, C., Brohawn, P. Z., Ge, X., Dong, Z., Yin, X., Zhu, G., Gu, Y., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-131 · Cited by 34

The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia

Sheth, K., & Cheson, B. D. (2016) · Therapeutic Advances in Hematology · doi:10.1177/2040620715625966 · Cited by 33

Regulation of Breast Cancer Metastasis by IGF Signaling

Sachdev, D. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9105-5 · Cited by 32

Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model

Tessitore, A., Mastroiaco, V., Vetuschi, A., Sferra, R., Pompili, S., Cicciarelli, G., Barnabei, R., Capece, D., Zazzeroni, F., Capalbo, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18585 · Cited by 32

Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor

Forest, A., Amatulli, M., Ludwig, D. L., Damoci, C. B., Wang, Y., Burns, C. A., Donoho, G. P., Zanella, N., Fiebig, H., Prewett, M. C., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0279 · Cited by 31

Role of p110a subunit of PI3-kinase in skeletal muscle mitochondrial homeostasis and metabolism

Li, M. E., Lauritzen, H. P. M. M., O'Neill, B. T., Wang, C., Cai, W., Brandão, B. B., Sakaguchi, M., Tao, R., Hirshman, M. F., Softic, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11265-y · Cited by 31

EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice

Zelenko, Z., Gallagher, E. J., Antoniou, I. M., Sachdev, D., Nayak, A., Yee, D., & LeRoith, D. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0142 · Cited by 30

Investigating New Therapeutic Strategies Targeting Hyperinsulinemia's Mitogenic Effects in a Female Mouse Breast Cancer Model

Rostoker, R., Bitton-Worms, K., Caspi, A., Shen‐Orr, Z., & LeRoith, D. (2013) · Endocrinology · doi:10.1210/en.2012-2263 · Cited by 29

Importance of diabetes in inhibition of pancreatic cancer by streptozotocin

Bell, R. H., Sayers, H. J., Pour, P. M., Ray, M. B., & McCullough, P. J. (1989) · Journal of Surgical Research · doi:10.1016/0022-4804(89)90170-4 · Cited by 29

Abdominal adipocyte populations in women with visceral obesity

Michaud, A., Laforest, S., Pelletier, M., Nadeau, M., Simard, S., Daris, M., Lebœuf, M., Vidal, H., Géloën, A., & Tchernof, A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0822 · Cited by 28

Diabetes, Metformin, and Breast Cancer: Lilac Time?

Goodwin, P. J., Thompson, A. M., & Stambolic, V. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.3319 · Cited by 26

Pancreatic carcinogenicity of N-nitrosobis(2-oxopropyl)-amine in diabetic and non-diabetic Chinese hamsters

Bell, R. H., & Pour, P. M. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90014-0 · Cited by 26

Comparison of solubilized and purified plasma membrane and nuclear insulin receptors

Wong, K., Hawley, D. M., Vigneri, R., & Goldfine, I. D. (1988) · Biochemistry · doi:10.1021/bi00401a056 · Cited by 20

Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model

Arcidiacono, D., Dedja, A., Giacometti, C., Fassan, M., Nucci, D., Francia, S., Fabris, F., Zaramella, A., Gallagher, E. J., Cassaro, M., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041198 · Cited by 19

OP449 inhibits breast cancer growth without adverse metabolic effects

Shlomai, G., Zelenko, Z., Antoniou, I. M., Stasinopoulos, M., Tobin‐Hess, A., Vitek, M. P., LeRoith, D., & Gallagher, E. J. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0077 · Cited by 16

Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice

Ben-Shmuel, S., Scheinman, E. J., Rashed, R., Orr, Z. S., Gallagher, E. J., LeRoith, D., & Rostoker, R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0310 · Cited by 15

Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis

Lkhagvadorj, S., Oh, S., Lee, M.-R., Jung, J. H., Chung, H. C., Cha, S., & Eom, M. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.4.861 · Cited by 14

Insulin Receptor at the Mouse Hepatocyte Nucleus after a Glucose Meal Induces Dephosphorylation of a 30-kDa Transcription Factor and a Concomitant Increase in Malic Enzyme Gene Expression

Gletsu-Miller, N. A., Dixon, W. T., & Clandinin, M. T. (1999) · Journal of Nutrition · doi:10.1093/jn/129.12.2154 · Cited by 14

Inverse relationship between insulin receptor expression and progression in renal cell carcinoma

Takahashi, M., Inoue, T., Huang, M., Numakura, K., Tsuruta, H., Saito, M., Maeno, A., Nakamura, E., Narita, S., Tsuchiya, N., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5552 · Cited by 13

Obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon

Santoro, M. A., Blue, R. E., Andres, S. F., Mah, A. T., Landeghem, L. V., & Lund, P. K. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00189.2015 · Cited by 12

Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study

Walraven, I., Riet, E. V. ‘., Stehouwer, C. D. A., Polak, B. C. P., Moll, A. C., Dekker, J. M., & Nijpels, G. (2013) · Diabetologia · doi:10.1007/s00125-013-2864-6 · Cited by 12

Interplay of Liver Disease and Gut Microbiota in the Development of Colorectal Neoplasia

Gleeson, M. W. (2019) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-019-00241-6 · Cited by 6

Molecular and cellular mechanisms governing the ligand-specific and non-specific steps of insulin receptor internalization.

Jl, C., Hamer, I., Gilbert, A., & Paccaud, J. P. (1996) · PubMed · Cited by 4

Definition and diagnostic criteria of clinical obesity

Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00316-4 · Cited by 1,811

Metabolomics in cancer research and emerging applications in clinical oncology

Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 675

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 463

Tumour fatty acid metabolism in the context of therapy resistance and obesity

Hoy, A. J., Nagarajan, S. R., & Butler, L. M. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00388-4 · Cited by 415

Hyperinsulinemia in Obesity, Inflammation, and Cancer

Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 344

Insulin resistance and hyperinsulinaemia in the development and progression of cancer

Godsland, I. F. (2009) · Clinical Science · doi:10.1042/cs20090399 · Cited by 233

Hyperinsulinaemia and cancer risk: cause and effect?

Kilvert, A., & Fox, C. (2020) · Practical Diabetes · doi:10.1002/pdi.2310 · Cited by 10

Insulin Resistance: The Increased Risk of Cancers

Szablewski, L. (2024) · Current Oncology · doi:10.3390/curroncol31020075 · Cited by 123

A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors

Westley, R., & May, F. E. B. (2013) · International Journal of Endocrinology · doi:10.1155/2013/632461 · Cited by 60

Rethinking the Relationship between Insulin and Cancer

Vigneri, R., Sciacca, L., & Vigneri, P. G. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.05.004 · Cited by 90